Since the majority of produced VEGF is sequestered in the ECM deposited by tumor and stromal cells, the proteolytic release of angiogenic factors from tissue matrix, mainly mediated by MMP-2 and MMP-9, is essential for in vivo induced angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.